We are live on ! Find out more
SILO icon

Silo Pharma
SILO

15 hedge funds and large institutions have $162K invested in Silo Pharma in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

36% more funds holding

Funds holding: 11 → 15 (+4)

0.23% less ownership

Funds ownership: 0.5% → 0.27% (-0.23%)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

56% less capital invested

Capital invested by funds: $371K → $162K (-$209K)

Holders
15
Holders Change
+4
Holders Change %
+36.36%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$20.7K
2
XT
XTX Topco
Cayman Islands
+$15K
3
HF
HRT Financial
New York
+$11.8K
4
TSS
Two Sigma Securities
New York
+$11.7K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$4.32K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$195K
2
Citadel Advisors
Citadel Advisors
Florida
-$15.8K
3
VF
Virtu Financial
New York
-$15.7K
4
Lazard Asset Management
Lazard Asset Management
New York
-$62
5
JP Morgan Chase
JP Morgan Chase
New York
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$33.4K -$195K -12,634 -83%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$31.1K +$4.32K +279 +14%
UBS Group
3
UBS Group
Switzerland
$17.9K +$20.7K +1,339 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$14.5K – – –
XT
5
XTX Topco
Cayman Islands
$13K +$15K +971 New
State Street
6
State Street
Massachusetts
$11.1K – – –
TSS
7
Two Sigma Securities
New York
$10.1K +$11.7K +758 New
HF
8
HRT Financial
New York
$10K +$11.8K +763 New
VF
9
Virtu Financial
New York
$9K -$15.7K -1,013 -59%
FDCDDQ
10
Federation des caisses Desjardins du Quebec
Quebec, Canada
$5.34K – – –
TRCT
11
Tower Research Capital (TRC)
New York
$4.05K +$495 +32 +12%
Citigroup
12
Citigroup
New York
$2.4K +$2.77K +179 New
WIM
13
Westside Investment Management
California
$84 – – –
Bank of America
14
Bank of America
North Carolina
$32 – – –
Citadel Advisors
15
Citadel Advisors
Florida
– -$15.8K -958 Closed
Lazard Asset Management
16
Lazard Asset Management
New York
– -$62 -4 -6%
JP Morgan Chase
17
JP Morgan Chase
New York
– -$1 – –

SILO Hedge Fund Activity: Q4 2024 in Review

15 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Silo Pharma (SILO) for Q4 2024, worth a combined $162K — down 56% from $371K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new SILO positions and 1 closed out — a net gain of 4 holders — while 2 added to existing stakes and 3 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $20.7K. The largest seller was Renaissance Technologies, cutting an estimated $195K.

  • 15 institutional investors held Silo Pharma (SILO) as of Q4 2024, up from 11 in Q3 2024.
  • Funds reported $162K of Silo Pharma stock for Q4 2024, down 56% quarter-over-quarter.
  • 5 funds opened new Silo Pharma positions in Q4 2024 and 1 closed out, a net change of +4 holders.
  • The largest Silo Pharma buyer in Q4 2024 was UBS Group, an estimated $20.7K added.
  • The largest Silo Pharma seller in Q4 2024 was Renaissance Technologies, an estimated $195K sold.

Based on aggregated 13F filings for Q4 2024.